Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-21-035774
Filing Date
2021-03-15
Accepted
2021-03-12 21:41:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm219631-1_424b5.htm 424B5 485916
2 GRAPHIC image_001.jpg GRAPHIC 2055
3 GRAPHIC image_002.jpg GRAPHIC 10377
  Complete submission text file 0001104659-21-035774.txt   504418
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-231923 | Film No.: 21739595
SIC: 2834 Pharmaceutical Preparations